transgenic expression of UPRT as a novel tool for tagging RNA in specific tissues of the mouse
transgenic expression of UPRT as a novel tool for tagging RNA in specific tissues of the mouse
批准号:
BB/K013424/1
负责人:
Martin Turner
金额:
$13.98万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2013
资助国家:
英国
项目状态:
已结题
起止时间:
2013 至 --
中文摘要
摘要(Lay)RNA是利用DNA编码的信息合成的,它调节基因组的许多功能,并产生蛋白质。了解RNA的调节是理解细胞功能的首要任务。与DNA序列一样,RNA序列由四个碱基组成,但与DNA不同的是,RNA含有由嘧啶尿嘧啶组成的核苷尿苷。尿嘧啶没有被结合到老鼠或人类细胞的RNA中,因为这一途径所需的酶在哺乳动物基因组中没有编码。因此,控制表达的尿嘧啶磷酸核糖转移酶(UPRT)将尿嘧啶转化为尿苷一磷酸,从而允许尿嘧啶以细胞类型特异的或时间控制的方式标记RNA。我们已经产生了一种以可控的方式表达UPRT的转基因小鼠,我们想要证明它作为一种工具的广泛用途,用于纯化RNA或识别复杂细胞混合物中稀有细胞亚群中的RNA蛋白质相互作用。这是一项改进,因为它将打开获取某些细胞类型的RNA组成的途径,这些细胞类型不容易纯化。此外,已知的纯化行为会改变细胞内RNA的数量和质量。因此,通过减少操作次数,将获得更准确的RNA含量或RNA-蛋白质相互作用的读数。
英文摘要
Summary (Lay)RNA is synthesised using information encoded by DNA and it mediates many of the functions of the genome as well as producing proteins. Understanding the regulation of RNA is a priority for the understanding of cell function. Like DNA sequences, RNA sequences are made up for four bases, but, unlike DNA, RNA contains the nucleoside uridine which is composed of the pyrimidine uracil. Uracil is not incorporated into the RNA of mouse or human cells as the required enzymes for this pathway are not encoded in the mammalian genome. Consequently, controlled expression of the enzyme uracil phosphoribosyltransferase (UPRT) which converts uracil into uridine monophosphate allows the incorporation of uracil in cell-type specific or temporally controlled manner labelling of RNA. We have generated a transgenic mouse that expresses UPRT in a controllable way and we want to demonstrate the broad utility of this as a tool for purification of RNA or the identification of RNA protein interactions in rare cell subsets in complex mixtures of cells. This is an improvement because it will open access to the RNA makeup of some cell types that cannot be easily purified. Furthermore, the act of purification is known to change the quantity and quality of the RNA within the cell. Thus by reducing the numbers of manipulations a more accurate readout of RNA content or RNA-protein interactions will be obtained.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms restraining the accumulation of antibody secreting cells
-
批准号:BB/W015242/1
-
项目类别:Research Grant
-
资助金额:$95.83万
-
财政年份:2023
-
负责人:Martin Turner
-
依托单位:
PTBP proteins in T cell activation: Cellular and molecular mechanisms of action
-
批准号:BB/P01898X/1
-
项目类别:Research Grant
-
资助金额:$95.79万
-
财政年份:2017
-
负责人:Martin Turner
-
依托单位:
Testing the Mechanism of T lymphocyte selection in the thymus mediated by the zfp36 family of RNA binding proteins
-
批准号:MR/N010434/1
-
项目类别:Research Grant
-
资助金额:$47.72万
-
财政年份:2016
-
负责人:Martin Turner
-
依托单位:
Dissecting the molecular mechanisms of PI3K in Extra-Follicular Helper and Regulatory T cell differentiation
-
批准号:BB/M021343/1
-
项目类别:Research Grant
-
资助金额:$49.74万
-
财政年份:2015
-
负责人:Martin Turner
-
依托单位:
Developing The Oxford Study for Biomarkers in Motor Neuron Disease (BioMOx): Capturing pre-symptomatic events and advancing clinical translation
-
批准号:MR/K01014X/1
-
项目类别:Fellowship
-
资助金额:$203.88万
-
财政年份:2013
-
负责人:Martin Turner
-
依托单位:
Sampling, biomarker OPtimization and Harmonization In ALS (SOPHIA)
-
批准号:MR/K000780/1
-
项目类别:Research Grant
-
资助金额:$9.31万
-
财政年份:2012
-
负责人:Martin Turner
-
依托单位:
Cell-intrinsic roles of P110delta in primary and memory antibody responses
-
批准号:BB/I01246X/1
-
项目类别:Research Grant
-
资助金额:$56.62万
-
财政年份:2012
-
负责人:Martin Turner
-
依托单位:
RNA processing mechanisms control lymphocyte development and activation
-
批准号:BB/J00152X/1
-
项目类别:Research Grant
-
资助金额:$367.89万
-
财政年份:2012
-
负责人:Martin Turner
-
依托单位:
PI3Kdelta regulation of influenza virus morbidity
-
批准号:G1001068/1
-
项目类别:Research Grant
-
资助金额:$63.13万
-
财政年份:2011
-
负责人:Martin Turner
-
依托单位:
Methods for Producing T lymphocytes in vitro from Stem Cells
-
批准号:BB/H023690/1
-
项目类别:Research Grant
-
资助金额:$13.48万
-
财政年份:2010
-
负责人:Martin Turner
-
依托单位:
Genetic analysis of the role of the PI3K signalling in humoral immunity
-
批准号:BB/E021638/1
-
项目类别:Research Grant
-
资助金额:$50.46万
-
财政年份:2008
-
负责人:Martin Turner
-
依托单位:
Biomarkers in motor neuron disease - a longitudinal translational neuroimaging and CSF study
-
批准号:G0701923/1
-
项目类别:Fellowship
-
资助金额:$130.89万
-
财政年份:2008
-
负责人:Martin Turner
-
依托单位:
PI3K signalling and T lymphocyte development
-
批准号:BB/F02066X/1
-
项目类别:Research Grant
-
资助金额:$67.27万
-
财政年份:2008
-
负责人:Martin Turner
-
依托单位:
Molecular mechanisms of B Lymphocyte differentiation and activation
-
批准号:G0601618/1
-
项目类别:Fellowship
-
资助金额:$179.08万
-
财政年份:2007
-
负责人:Martin Turner
-
依托单位:
国内基金
海外基金
登录
查看更多内容
缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
-
批准号:82370751
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:张明
-
依托单位:
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
-
批准号:82371317
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:万杰清
-
依托单位:
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
-
批准号:82370906
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:代杰文
-
依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
-
批准号:82371141
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈颖
-
依托单位:
骨骼肌中胰高血糖素受体的表达及其调控血糖稳态的作用与机制研究
-
批准号:82370820
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王天歌
-
依托单位:
lncGEI诱导湖羊卵巢颗粒细胞E2合成的分子机制
-
批准号:32372856
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李隐侠
-
依托单位:
转录因子LEF1低表达抑制HMGB1致子宫腺肌病患者子宫内膜容受性低下的分子机制
-
批准号:82371704
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:徐步芳
-
依托单位:
NFATc3转录调控MMP14介导少突胶质细胞瘤血管新生促肿瘤恶变的机制研究
-
批准号:32100563
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:齐琳
-
依托单位:
低氧相关lncRNA UTGF调控TGF-β信号传导及转移的作用及机制
-
批准号:32100573
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:伍梦芝
-
依托单位:
小鼠肺分支早期发育中肺上皮单细胞的时-空转录组的建立与分析
-
批准号:32070795
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:蔡军
-
依托单位: